Vector BioMed raised $15 million in a first round of funding as the startup looks to help fill a big gap in the manufacture of cell and gene therapies. The latest entry into the CDMO viral vector ...
Cell and gene therapies rely on engineered viruses to deliver them to their cellular destinations. While the progress of these types of medicines is evident in a growing number of FDA product ...
WEST JEFFERSON, OH and GAITHERSBURG, MD / ACCESSWIRE / October 31, 2023 / AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, and Vector BioMed, a ...
Led by a local industry veteran, startup Vector BioMed aims to fill a "significant market need." Maryland biotech raises $75M to speed treatment for rare diseases Maryland biotech starts clinical ...
Lentiviral expert, Dr. Reiser joins Vector BioMed after serving as principal investigator at the FDA's Center for Biologics Evaluation and Research (CBER) "Dr. Reiser is a key addition to Vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results